Trial Profile
A phase I trial of NOD Pharmaceuticals' oral insulin formulation, in diabetic patients in China.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- 15 Jul 2011 New trial record